Eledon Pharmaceuticals (ELDN) Short-term Investments (2016 - 2026)
Eledon Pharmaceuticals posted quarterly Short-term Investments of $104.9 million for Q1 2026, down 9.84% year-on-year from $116.4 million in Q1 2025, and down 5.06% on a QoQ basis from $110.5 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 6 years of Short-term Investments data on file, last reported at $104.9 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments fell 9.84% year-over-year to $104.9 million; the trailing twelve-month figure through Mar 2026 stood at $104.9 million (down 9.84% YoY), and the FY2025 full-year result was $110.5 million, down 7.61% from the prior year.
- Short-term Investments for Q1 2026 stood at $104.9 million, down from $110.5 million in the prior quarter.
- Across five years, Short-term Investments topped out at $119.6 million in Q4 2024 and bottomed at $30.4 million in Q2 2023.
- The 4-year median for Short-term Investments is $80.6 million (2024), against an average of $78.5 million.
- The widest annual swing landed in 2025, when Short-term Investments soared 212.8%; it then slipped 9.84% in 2026.
- A 4-year view of Short-term Investments shows it stood at $46.5 million in 2023, then soared by 157.32% to $119.6 million in 2024, then dropped by 7.61% to $110.5 million in 2025, then decreased by 5.06% to $104.9 million in 2026.
- The last three Short-term Investments figures came in at $104.9 million (Q1 2026), $110.5 million (Q4 2025), and $89.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.94 Mn |
| Dec 31, 2025 | 110.53 Mn |
| Sep 30, 2025 | 89.73 Mn |
| Jun 30, 2025 | 101.83 Mn |
| Mar 31, 2025 | 116.39 Mn |
| Dec 31, 2024 | 119.63 Mn |
| Sep 30, 2024 | 71.44 Mn |
| Jun 30, 2024 | 57.57 Mn |
| Mar 31, 2024 | 37.21 Mn |
| Dec 31, 2023 | 46.49 Mn |
| Sep 30, 2023 | 55.94 Mn |
| Jun 30, 2023 | 30.43 Mn |
| Dec 31, 2017 | 70,000.00 |
| Jun 30, 2017 | 13,000.00 |
| Dec 31, 2016 | 14,000.00 |